Biotech developing oral small molecule degraders for extracellular proteins.
| Date | Round | Amount |
|---|---|---|
| Jul 2024 | Seed Draupnir Bio raised a €12M seed round from MP Healthcare, EIFO and existing investors to advance its targeted protein degradation pipeline. | $12.6M |